Form 8-K - Current report:
SEC Accession No. 0000950170-22-026764
Filing Date
2022-12-19
Accepted
2022-12-19 17:28:03
Documents
13
Period of Report
2022-12-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nari-20221216.htm   iXBRL 8-K 61726
2 EX-10.1 nari-ex10_1.htm EX-10.1 311553
  Complete submission text file 0000950170-22-026764.txt   519591

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nari-20221216_pre.xml EX-101.PRE 9453
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nari-20221216.xsd EX-101.SCH 2469
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nari-20221216_lab.xml EX-101.LAB 12806
7 EXTRACTED XBRL INSTANCE DOCUMENT nari-20221216_htm.xml XML 4516
Mailing Address 6001 OAK CANYON, SUITE 100 IRVINE CA 92618
Business Address 6001 OAK CANYON, SUITE 100 IRVINE CA 92618 949-923-4747
Inari Medical, Inc. (Filer) CIK: 0001531048 (see all company filings)

IRS No.: 452902923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39293 | Film No.: 221472165
SIC: 3841 Surgical & Medical Instruments & Apparatus